Join to View Full Profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 800-926-8273
Dr. Drygalski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2004 - 2007
Ludwig Maximilian University of Munich Faculty of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 2007 - 2027
WI State Medical License 2005 - 2011
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B Start of enrollment: 2013 Feb 11
Publications & Presentations
PubMed
- 2 citationsCompletion of phase 2b trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B over 5 years.Annette von Drygalski, Esteban Gomez, Adam Giermasz, Giancarlo Castaman, Nigel S Key
Blood Advances. 2025-07-22 - Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report.Hanny Al-Samkari, Raj S Kasthuri, Hans-Jurgen Mager, Jenny Y Zhou, Marcelo M Serra
American Journal of Hematology. 2025-07-15 - Proactive measures to reduce maternal mortality and post-partum hemorrhage in sub-Saharan Africa: the hematology perspective.Bilgimol Chumappumkal Joseph, Esther Chioma Emenalom, Patrícia Silva, Annette von Drygalski
Expert Review of Hematology. 2025-07-01
Journal Articles
- Development and Reliability of the Joint Tissue Activity and Damage Examination for Quantitation of Structural Abnormalities by Musculoskeletal Ultrasound in Hemophili...Eric Y Chang, Annette von Drygalski, Doris V Quon, Tudor H Hughes, Journal of Ultrasound in Medicine
Abstracts/Posters
- Quantitative Measurements of Hemophilic Joint Tissues By Point-of-Care Musculoskeletal Ultrasound Are Associated with Clinical and Functional Joint Outcome ParametersAnnette von Drygalski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Superfactor Va, an Engineered Factor V Molecule, Effectively Reduces Bleeding and Acute Coagulopathy in Mouse Models of Trauma and ShockAnnette von Drygalski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Mechanisms of Iron Clearance from the Joint in FVIII-Deficient Mice after Induced HemarthrosisAnnette von Drygalski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
Hemophilia B: Gene Therapy Shows 5-Year SuccessJuly 25th, 2025- Anemia, Postpartum Hemorrhage, and Maternal Death: An Intervention in Africa Has Global Implications for Improving OutcomesFebruary 4th, 2025
- UC San Diego Health First to Offer Novel Gene Therapy for Hemophilia BJanuary 8th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
